Bimatoprost/Timolol Versus Travoprost/Timolol

Bimatoprost/Timolol Versus Travoprost/Timolol Fixed Combinations in an Egyptian Population: A Hospital-Based Prospective Randomized Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01542710

Enrollment

Registered

2012-03-02

Start date

2011-01-31

Completion date

2011-12-31

Last updated

2012-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

The purpose of this study is to compare 2 fixed combination medications in intraocular pressure lowering.

Detailed description

PURPOSE: To compare the efficacy of bimatoprost/timolol (BTFC) or travoprost/timolol (TTFC) fixed combinations on intraocular pressure (IOP) reduction in an Egyptian population. METHODS: Patients with primary open angle glaucoma (POAG) were randomized to receive either BTFC or TTFC. IOPs were measured at baseline, 2 weeks, and 1, 2, 4, and 6 months. The primary outcome measures were the mean change in IOP from baseline

Interventions

DRUGGanfort

Bimatoprost/Timolol fixed combination

DRUGDuotrav

Fixed combination of Travoprost and Timolol

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Glaucoma

Exclusion criteria

* No other ocular diseases

Design outcomes

Primary

Measure	Time frame
Percentage of drop of intraocular pressures from baseline.	1 year

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026